A private equity and growth investor focused on technology and fintech, Michael Summers brings operational and capital-markets experience to deal sourcing, portfolio strategy and exits. He has led buyouts, growth equity and corporate development initiatives across software and financial services, overseeing value creation, M&A and fundraising. Prior roles span operating leadership at high-growth startups and senior investment-firm positions managing deal teams, due diligence and LP relations. Market strengths include transaction execution, scaling go-to-market and board-level governance.
A private equity and growth investor focused on technology and fintech, Michael Summers brings operational and capital-markets experience to deal sourcing, portfolio strategy and exits. He has led buyouts, growth equity and corporate development initiatives across software and financial services, overseeing value creation, M&A and fundraising. Prior roles span operating leadership at high-growth startups and senior investment-firm positions managing deal teams, due diligence and LP relations. Market strengths include transaction execution, scaling go-to-market and board-level governance.
Combines private equity discipline with growth-equity flexibility to back software and fintech companies capable of scaling revenue and unit economics. Prefers control or influential minority positions where operational levers—product-market fit, go-to-market expansion and governance—can be executed. Emphasizes rigorous due diligence, staged capital deployment and KPI-driven value creation plans tied to M&A or IPO exit paths. Time horizon balances multi-year scaling with opportunistic liquidity events; risk managed through operational involvement, conservative leverage and repeatable playbooks for commercialization and fundraising.
Combines private equity discipline with growth-equity flexibility to back software and fintech companies capable of scaling revenue and unit economics. Prefers control or influential minority positions where operational levers—product-market fit, go-to-market expansion and governance—can be executed. Emphasizes rigorous due diligence, staged capital deployment and KPI-driven value creation plans tied to M&A or IPO exit paths. Time horizon balances multi-year scaling with opportunistic liquidity events; risk managed through operational involvement, conservative leverage and repeatable playbooks for commercialization and fundraising.
| Trades 40 | Longs Won 6/40 15% | Profit Factor 0.41 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $5.41M |
| Average Win $6.27M | Best Trade (Oct 15) $18.89M | Sharpe Ratio -36.49 |
| Average Loss -$2.67M | Worst Trade (Oct 14) -$12.25M | Z-Score -1.1 (72.74%) |
| Commissions $0 | Avg. Trade Length 1y 4m 1w 3d | Expectancy -$1.33M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 140 | 126 | 112 | 98 | 84 | 70 | 56 | 42 | 28 | 14 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
EPAM Epam Systems Inc. | 1.37M | $181.98M | $165.04M | - | -$16.94M | -9.31% | +5.409% |
HDB HDFC Bank Limited ADR | 4.08M | $128.88M | $95.37M | - | -$33.51M | -26% | +3.248% |
INFY Infosys Limited | 352,907 | $6.45M | $4.21M | - | -$2.24M | -34.71% | +3.92% |
MMYT MakeMyTrip Limited | 525 | $27,977 | $24,024 | - | -$3,953 | -14.13% | +4.858% |
RDY Dr. Reddy's Laboratories Ltd. | 8.49M | $119.81M | $109.91M | - | -$9.9M | -8.26% | +1.49% |